METB-12. CLINICAL MONITORING OF MEASURABLE RESIDUAL DISEASE BY CELL-FREE DNA IN PEDIATRIC BRAIN TUMORS

Conventional response monitoring relies on imperfect tools like MRI and cerebrospinal fluid (CSF) cytology to detect measurable residual disease (MRD) in children with brain tumors. “Liquid biopsy” techniques provide a minimally-invasive method for MRD detection by identifying fragments of cell-free...

Descripción completa

Detalles Bibliográficos
Autores principales: Crotty, Erin, Cole, Bonnie, Paulson, Vera, Lockwood, Christina, Leary, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Genomics/Epigenomics/Metabolomics - METB
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260051/
http://dx.doi.org/10.1093/neuonc/noad073.129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260051/
http://dx.doi.org/10.1093/neuonc/noad073.129

Ejemplares similares